Background illustration for clinical trials search

Paid Clinical Trials Anaheim

Discover 3,573 paid clinical trials in Anaheim, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

for
Schizophrenia
Location: Pico Rivera CA, Bentonville AR, St Louis MO, Chicago IL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07467993

Phase 2, Recruiting

Food is Medicine Prospective Study

for
Wounds and Injuries
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT07169448

Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Duarte CA, Los Angeles CA, Scottsdale AZ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase 1, Recruiting

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

for
Aplastic Anemias, Hemoglobinopathies, Bone Marrow Failure
Location: Duarte CA, Portland OR, Seattle WA, Houston TX,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0+

Code: NCT07227155

Recruiting

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

for
Congenital Heart Disease, Congenital Heart Disease (CHD)
Location: Los Angeles CA, Stanford CA, Aurora CO, Seattle WA,
Sponsor: Starlight Cardiovascular Inc

Sex: All

Age: 0

Code: NCT07114718

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

for
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Location: Duarte CA, Tigard OR, Waukesha WI, Morgantown WV,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07564141

Phase 3, Recruiting

Digital vs. Parent Modeled Toothbrushing

for
Plaque Reduction
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 3 - 6

Code: NCT07441148

Recruiting

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Duarte CA, St Louis MO, Nashville TN, Atlanta GA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07544654

Phase 3, Recruiting

A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs

for
Nutrition Intake, Nutrition Status, Gastrointestinal Microbiome,
Location: Santa Monica CA
Sponsor: Athletic Greens International

Sex: All

Age: 18 - 59

Code: NCT07437911

Recruiting

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Los Angeles CA, Birmingham AL, Tampa FL, Charleston SC,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07098988

Phase 2, Recruiting

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

for
Advanced Pheochromocytoma and Paraganglioma, PCPG
Location: Los Angeles CA, Palo Alto CA, Salt Lake City UT,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07282587

Phase 2, Recruiting

Pituitary Tumor Surveillance: Pathogenic Correlation

for
Pituitary Tumor
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT00599092

Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Duarte CA, Goodyear AZ, Houston TX, St Louis MO,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07594106

Phase 1, Phase 2, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Duarte CA, Glendale CA, Los Angeles CA, Murrieta CA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase 1, Phase 2, Recruiting

OM336 in Autoimmune Cytopenias

for
AIHA - Warm Autoimmune Hemolytic Anemia,
Location: Duarte CA, Seattle WA, Ann Arbor MI, Washington D.C. DC
Sponsor: Lakefront Biotherapeutics West LLC

Sex: All

Age: 18 - 70+

Code: NCT07083960

Phase 1, Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Location: Fullerton CA, Huntington Beach CA, Torrance CA,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07482176

Phase 3, Recruiting

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease

for
Steroid Refractory GVHD
Location: Duarte CA, Los Angeles CA, St Louis MO, Cincinnati OH,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 12+

Code: NCT06343792

Phase 2, Recruiting

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

for
Chronic Graft Versus Host Disease
Location: Duarte CA, Seattle WA, Tampa FL, New York NY, Boston MA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT05996627

Phase 2, Recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

for
AIDS-Related Diffuse Large B-cell Lymphoma,
Location: Duarte CA, Salt Lake City UT, Chicago IL, Columbus OH,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05077527

Phase 1, Recruiting

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis
Location: Duarte CA, Seattle WA, Houston TX, Ann Arbor MI,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04485260

Phase 1, Phase 2, Recruiting